● Recruiting

Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy

Condition: Oesophageal Adenocarcinoma · Tumor Microenvironment · Sponsor: Amsterdam UMC, location VUmc

PhasePhase 2

Planned participants14

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The primary objective of this study is to investigate whether two weeks of metformin treatment can activate the tumour microenvironment in patients with stage II and III oesophageal adenocarcinomas.

This description comes directly from the study's public registry record.

Talk to the study team

Kayla Brugman, Master of Medicine · +3120 44 45869 · c.brugman@amsterdamumc.nl

Always discuss trial participation with your own doctor first.

Locations (2)

Amsterdam UMC	Amsterdam, Netherlands	Not Yet Recruiting
Amsterdam UMC	Amsterdam, Netherlands	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06687876